Global In Vitro Toxicity Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1061

In Vitro Toxicity is a scientific method of testing toxic chemical substances on cultured bacteria or mammalian cells.
In 2018, the global In Vitro Toxicity market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global In Vitro Toxicity status, future forecast, growth opportunity, key market and key players. The study objectives are to present the In Vitro Toxicity development in United States, Europe and China.

The key players covered in this study
Agilent Technologies
Covance
Bio-Rad Laboratories
General Electric
Eurofins Scientific
BioReliance
Charles River Laboratories International
Thermo Fisher Scientific
Catalent
Cyprotex

Market segment by Type, the product can be split into
Dose Response
Threshold Response

Market segment by Application, split into
Distribution
Excretion
Metabolism

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global In Vitro Toxicity status, future forecast, growth opportunity, key market and key players.
To present the In Vitro Toxicity development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of In Vitro Toxicity are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global In Vitro Toxicity Market Size Growth Rate by Type (2014-2025)
1.4.2 Dose Response
1.4.3 Threshold Response
1.5 Market by Application
1.5.1 Global In Vitro Toxicity Market Share by Application (2014-2025)
1.5.2 Distribution
1.5.3 Excretion
1.5.4 Metabolism
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 In Vitro Toxicity Market Size
2.2 In Vitro Toxicity Growth Trends by Regions
2.2.1 In Vitro Toxicity Market Size by Regions (2014-2025)
2.2.2 In Vitro Toxicity Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 In Vitro Toxicity Market Size by Manufacturers
3.1.1 Global In Vitro Toxicity Revenue by Manufacturers (2014-2019)
3.1.2 Global In Vitro Toxicity Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global In Vitro Toxicity Market Concentration Ratio (CR5 and HHI)
3.2 In Vitro Toxicity Key Players Head office and Area Served
3.3 Key Players In Vitro Toxicity Product/Solution/Service
3.4 Date of Enter into In Vitro Toxicity Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global In Vitro Toxicity Market Size by Type (2014-2019)
4.2 Global In Vitro Toxicity Market Size by Application (2014-2019)

5 United States
5.1 United States In Vitro Toxicity Market Size (2014-2019)
5.2 In Vitro Toxicity Key Players in United States
5.3 United States In Vitro Toxicity Market Size by Type
5.4 United States In Vitro Toxicity Market Size by Application

6 Europe
6.1 Europe In Vitro Toxicity Market Size (2014-2019)
6.2 In Vitro Toxicity Key Players in Europe
6.3 Europe In Vitro Toxicity Market Size by Type
6.4 Europe In Vitro Toxicity Market Size by Application

7 China
7.1 China In Vitro Toxicity Market Size (2014-2019)
7.2 In Vitro Toxicity Key Players in China
7.3 China In Vitro Toxicity Market Size by Type
7.4 China In Vitro Toxicity Market Size by Application

8 Japan
8.1 Japan In Vitro Toxicity Market Size (2014-2019)
8.2 In Vitro Toxicity Key Players in Japan
8.3 Japan In Vitro Toxicity Market Size by Type
8.4 Japan In Vitro Toxicity Market Size by Application

9 Southeast Asia
9.1 Southeast Asia In Vitro Toxicity Market Size (2014-2019)
9.2 In Vitro Toxicity Key Players in Southeast Asia
9.3 Southeast Asia In Vitro Toxicity Market Size by Type
9.4 Southeast Asia In Vitro Toxicity Market Size by Application

10 India
10.1 India In Vitro Toxicity Market Size (2014-2019)
10.2 In Vitro Toxicity Key Players in India
10.3 India In Vitro Toxicity Market Size by Type
10.4 India In Vitro Toxicity Market Size by Application

11 Central & South America
11.1 Central & South America In Vitro Toxicity Market Size (2014-2019)
11.2 In Vitro Toxicity Key Players in Central & South America
11.3 Central & South America In Vitro Toxicity Market Size by Type
11.4 Central & South America In Vitro Toxicity Market Size by Application

12 International Players Profiles
12.1 Agilent Technologies
12.1.1 Agilent Technologies Company Details
12.1.2 Company Description and Business Overview
12.1.3 In Vitro Toxicity Introduction
12.1.4 Agilent Technologies Revenue in In Vitro Toxicity Business (2014-2019)
12.1.5 Agilent Technologies Recent Development
12.2 Covance
12.2.1 Covance Company Details
12.2.2 Company Description and Business Overview
12.2.3 In Vitro Toxicity Introduction
12.2.4 Covance Revenue in In Vitro Toxicity Business (2014-2019)
12.2.5 Covance Recent Development
12.3 Bio-Rad Laboratories
12.3.1 Bio-Rad Laboratories Company Details
12.3.2 Company Description and Business Overview
12.3.3 In Vitro Toxicity Introduction
12.3.4 Bio-Rad Laboratories Revenue in In Vitro Toxicity Business (2014-2019)
12.3.5 Bio-Rad Laboratories Recent Development
12.4 General Electric
12.4.1 General Electric Company Details
12.4.2 Company Description and Business Overview
12.4.3 In Vitro Toxicity Introduction
12.4.4 General Electric Revenue in In Vitro Toxicity Business (2014-2019)
12.4.5 General Electric Recent Development
12.5 Eurofins Scientific
12.5.1 Eurofins Scientific Company Details
12.5.2 Company Description and Business Overview
12.5.3 In Vitro Toxicity Introduction
12.5.4 Eurofins Scientific Revenue in In Vitro Toxicity Business (2014-2019)
12.5.5 Eurofins Scientific Recent Development
12.6 BioReliance
12.6.1 BioReliance Company Details
12.6.2 Company Description and Business Overview
12.6.3 In Vitro Toxicity Introduction
12.6.4 BioReliance Revenue in In Vitro Toxicity Business (2014-2019)
12.6.5 BioReliance Recent Development
12.7 Charles River Laboratories International
12.7.1 Charles River Laboratories International Company Details
12.7.2 Company Description and Business Overview
12.7.3 In Vitro Toxicity Introduction
12.7.4 Charles River Laboratories International Revenue in In Vitro Toxicity Business (2014-2019)
12.7.5 Charles River Laboratories International Recent Development
12.8 Thermo Fisher Scientific
12.8.1 Thermo Fisher Scientific Company Details
12.8.2 Company Description and Business Overview
12.8.3 In Vitro Toxicity Introduction
12.8.4 Thermo Fisher Scientific Revenue in In Vitro Toxicity Business (2014-2019)
12.8.5 Thermo Fisher Scientific Recent Development
12.9 Catalent
12.9.1 Catalent Company Details
12.9.2 Company Description and Business Overview
12.9.3 In Vitro Toxicity Introduction
12.9.4 Catalent Revenue in In Vitro Toxicity Business (2014-2019)
12.9.5 Catalent Recent Development
12.10 Cyprotex
12.10.1 Cyprotex Company Details
12.10.2 Company Description and Business Overview
12.10.3 In Vitro Toxicity Introduction
12.10.4 Cyprotex Revenue in In Vitro Toxicity Business (2014-2019)
12.10.5 Cyprotex Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details